- Email: [email protected]
Nanostart Asia Pacific invests further in MINT
NEWS/EXCHANGE RATES
Nanostart Asia Pacific Ahlstrom to close invests further in MINT Barcelona plant
N
anostart Asia Pacific Pte Ltd is increasing its stake in Singapore’s Membrane Instruments and Technologies Pte Ltd (MINT) from 18% to 28%. The investment in MINT will be through the Nanostart Early Stage Venture Fund I, which is managed by Nanostart Asia Pacific. The funds will be used for the marketing of MINT’s Membrane Integrity Sensor and its international rollout. The Membrane Integrity Sensor, which is MINT’s flagship product, is a sensitive analysis system for continuous and reliable online monitoring of water quality at water treatment facilities. The system was developed at the Nanyang Technological University (NTU) in Singapore and introduced to the market last year. The sensor is the first MINT product available on the market and is already in use at a number of facilities. MINT is a spin-off from Singapore’s NTU. Nanostart Asia Pacific is a venture capital investment company which invests in young, up-and-coming nanotechnology companies which are approaching market launch or have innovative products already on the market. It is a subsidiary of Germany’s Nanostart AG. For further information, visit www.mintmembranes.com, www.nanostart-asia-pacific.com and www.nanostart.de
A
hlstrom Corp is to shut its manufacturing plant in Barcelona, Spain later this year, with the loss of about 30 jobs. The Barcelona plant, which makes materials for advanced and transportation filtration applications and is one of Ahlstrom’s smallest production units, has suffered from continued weakening demand in Southern Europe. For further information, visit www.ahlstrom.com
GVS acquires medical filter products
I
taly’s GVS SpA has bought NP Medical Inc’s filter products business. The acquired products are made in Cayey, Puerto Rico and are marketed under NP Medical’s IVEX and Nutrivex brands. “Together with our existing line, SpeedFlow, the IVEX and Nutrivex business will allow our group to become a world leader in the IV filter business in terms of quantity and range of products,” said Massimo Scagliarini, GVS CEO. GVS manufactures filtration products primarily for the medical and automotive markets. For further information, visit www.gvs.com and www.nypro.com
Exchange Rates against the US Dollar Date: 22.6.2012 Country Australia
Rate A$0.99
Country Netherlands
Austria
E0.80
Norway
Belgium
E0.80
Philippines
C$1.02
Singapore
Canada
Rate E0.80 NOK5.96 Peso42.52 S$1.28
China
CNY6.37
South Africa
R8.41
Denmark
DKK5.91
South Korea
KWn1158.90
Finland
E0.80
Spain
France
E0.80
Sweden
SEK7.01
Germany
E0.80
Switzerland
CHF0.96
Taiwan
T$29.94
Thailand
Bt31.84
India Italy
Rp57.13 E0.80
Japan
¥80.43
UK
Malaysia
Rt3.20
USA
16
Filtration Industry Analyst
E0.80
£0.64
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: David Hopwood Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: 1232 for all European countries & Iran US$1382 for all countries except Europe and Japan ¥163 800 for Japan (Prices valid until 31 December 2012) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.filtrationindustryanalyst.com Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12976
US$1.00
June 2012
Nanostart Asia Pacific Ahlstrom to close invests further in MINT Barcelona plant
N
anostart Asia Pacific Pte Ltd is increasing its stake in Singapore’s Membrane Instruments and Technologies Pte Ltd (MINT) from 18% to 28%. The investment in MINT will be through the Nanostart Early Stage Venture Fund I, which is managed by Nanostart Asia Pacific. The funds will be used for the marketing of MINT’s Membrane Integrity Sensor and its international rollout. The Membrane Integrity Sensor, which is MINT’s flagship product, is a sensitive analysis system for continuous and reliable online monitoring of water quality at water treatment facilities. The system was developed at the Nanyang Technological University (NTU) in Singapore and introduced to the market last year. The sensor is the first MINT product available on the market and is already in use at a number of facilities. MINT is a spin-off from Singapore’s NTU. Nanostart Asia Pacific is a venture capital investment company which invests in young, up-and-coming nanotechnology companies which are approaching market launch or have innovative products already on the market. It is a subsidiary of Germany’s Nanostart AG. For further information, visit www.mintmembranes.com, www.nanostart-asia-pacific.com and www.nanostart.de
A
hlstrom Corp is to shut its manufacturing plant in Barcelona, Spain later this year, with the loss of about 30 jobs. The Barcelona plant, which makes materials for advanced and transportation filtration applications and is one of Ahlstrom’s smallest production units, has suffered from continued weakening demand in Southern Europe. For further information, visit www.ahlstrom.com
GVS acquires medical filter products
I
taly’s GVS SpA has bought NP Medical Inc’s filter products business. The acquired products are made in Cayey, Puerto Rico and are marketed under NP Medical’s IVEX and Nutrivex brands. “Together with our existing line, SpeedFlow, the IVEX and Nutrivex business will allow our group to become a world leader in the IV filter business in terms of quantity and range of products,” said Massimo Scagliarini, GVS CEO. GVS manufactures filtration products primarily for the medical and automotive markets. For further information, visit www.gvs.com and www.nypro.com
Exchange Rates against the US Dollar Date: 22.6.2012 Country Australia
Rate A$0.99
Country Netherlands
Austria
E0.80
Norway
Belgium
E0.80
Philippines
C$1.02
Singapore
Canada
Rate E0.80 NOK5.96 Peso42.52 S$1.28
China
CNY6.37
South Africa
R8.41
Denmark
DKK5.91
South Korea
KWn1158.90
Finland
E0.80
Spain
France
E0.80
Sweden
SEK7.01
Germany
E0.80
Switzerland
CHF0.96
Taiwan
T$29.94
Thailand
Bt31.84
India Italy
Rp57.13 E0.80
Japan
¥80.43
UK
Malaysia
Rt3.20
USA
16
Filtration Industry Analyst
E0.80
£0.64
Editorial Office: Elsevier Limited The Boulevard, Langford Lane Kidlington Oxford OX5 1GB United Kingdom Tel: +44 (0) 1865 843695 Fax: +44 (0) 1865 843973 Web: www.filtrationindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Publisher: David Hopwood Subscription Information An annual subscription to Filtration Industry Analyst includes 12 issues and online access for up to 5 users. Prices: 1232 for all European countries & Iran US$1382 for all countries except Europe and Japan ¥163 800 for Japan (Prices valid until 31 December 2012) To subscribe send payment to the address above. Tel: +44 (0)1865 843687 or via www.filtrationindustryanalyst.com Subscriptions run for 12 months, from the date payment is received. Permissions may be sought directly from Elsevier Global Rights Department, PO Box 800, Oxford OX5 1DX, UK; phone: +44 1865 843830, fax: +44 1865 853333, email: [email protected]. You may also contact Global Rights directly through Elsevier’s home page (www.elsevier.com), selecting first ‘Support & contact’, then ‘Copyright & permission’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: +1 978 750 8400, fax: +1 978 750 4744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: +44 (0)20 7631 5555; fax: +44 (0)20 7631 5500. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Address permissions requests to: Elsevier Science Global Rights Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/ or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) LImited 12976
US$1.00
June 2012